DoubleLine ETF Adviser
TMO icon

DoubleLine ETF Adviser’s Thermo Fisher Scientific TMO Stock Holding History

DoubleLine ETF Adviser’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,270
Closed -$2.14M – 225
2026
Q2 		$2.14M Sell
4,270
-434
-9% -$208K 0.88% 38
2026
Q1 		$2.31M Buy
+4,704
New +$2.55M 0.88% 31

Other funds holding TMO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

DoubleLine ETF Adviser's TMO Position: Q3 2026 in Review

DoubleLine ETF Adviser sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 4,270 shares — an estimated $2.14M sold.

DoubleLine ETF Adviser first reported a position in TMO in Q1 2026 and held it in 2 quarters. The position peaked at $2.31M in Q1 2026. 2,399 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • DoubleLine ETF Adviser reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 4,270 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.14M.
  • DoubleLine ETF Adviser first reported a position in Thermo Fisher Scientific in Q1 2026 and held it in 2 quarters.
  • DoubleLine ETF Adviser's Thermo Fisher Scientific position peaked at $2.31M in Q1 2026.
  • 2,399 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q3 2026, filed 13 Nov 2026.